| pubmed-article:1715079 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1715079 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:1715079 | lifeskim:mentions | umls-concept:C0007134 | lld:lifeskim |
| pubmed-article:1715079 | lifeskim:mentions | umls-concept:C1518453 | lld:lifeskim |
| pubmed-article:1715079 | lifeskim:mentions | umls-concept:C0449820 | lld:lifeskim |
| pubmed-article:1715079 | lifeskim:mentions | umls-concept:C0750480 | lld:lifeskim |
| pubmed-article:1715079 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:1715079 | pubmed:dateCreated | 1991-9-20 | lld:pubmed |
| pubmed-article:1715079 | pubmed:abstractText | The proliferative activity of 21 cases of renal cell carcinoma has been investigated by means of monoclonal antibody Ki-67 and Nucleolar Organizer Regions (AgNORs) analysis. The correlation between AgNOR counts and Ki-67 scores was only slightly significant (r = 0.53, r2 = 0.28) as determined by linear regression. Positive correlation was found between Ki-67 scores and tumour histologic grade. However, no correlation was observed between Ki-67 scores and tumour pathologic stage and between AgNOR counts and tumour histologic grade and/or pathologic stage. The results suggest that AgNOR counts cannot replace Ki-67 scores in evaluating the proliferative activity of renal cell carcinoma and that such activity and both histologic grade and pathologic stage seem to be independent parametres. | lld:pubmed |
| pubmed-article:1715079 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1715079 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1715079 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1715079 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1715079 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1715079 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1715079 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1715079 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1715079 | pubmed:month | May | lld:pubmed |
| pubmed-article:1715079 | pubmed:issn | 0344-0338 | lld:pubmed |
| pubmed-article:1715079 | pubmed:author | pubmed-author:ValentiCC | lld:pubmed |
| pubmed-article:1715079 | pubmed:author | pubmed-author:StramignoniAA | lld:pubmed |
| pubmed-article:1715079 | pubmed:author | pubmed-author:MargariaEE | lld:pubmed |
| pubmed-article:1715079 | pubmed:author | pubmed-author:PichAA | lld:pubmed |
| pubmed-article:1715079 | pubmed:author | pubmed-author:AzzoniLL | lld:pubmed |
| pubmed-article:1715079 | pubmed:author | pubmed-author:TassoMM | lld:pubmed |
| pubmed-article:1715079 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1715079 | pubmed:volume | 187 | lld:pubmed |
| pubmed-article:1715079 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1715079 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1715079 | pubmed:pagination | 482-6 | lld:pubmed |
| pubmed-article:1715079 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:meshHeading | pubmed-meshheading:1715079-... | lld:pubmed |
| pubmed-article:1715079 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1715079 | pubmed:articleTitle | Argyrophilic nucleolar organizer region counts and Ki-67 scores in human renal cell carcinoma. | lld:pubmed |
| pubmed-article:1715079 | pubmed:affiliation | Department of Biomedical Sciences and Human Oncology, University of Turin, Italy. | lld:pubmed |
| pubmed-article:1715079 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1715079 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1715079 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1715079 | lld:pubmed |
